Post

Barinthus Bio slashes headcount by 25% and refocuses pipeline

Much like the mythological navigator from which it takes its name, Barinthus Biotherapeutics is steering a new course of pipeline …

Palatin Technologies commences Phase II study of obesity treatment

Palatin Technologies has commenced a Phase II clinical trial of breatelanotide, a melanocortin 4 receptor (MC4R) agonist, to treat obesity. The …

FDA grants IND clearance for Allay’s trial of post-surgical pain treatment

The US Food and Drug Administration (FDA) has granted clearance to Allay Therapeutics’ investigational new drug (IND) application to initiate …

Gender and migraine: an epidemiological review

Migraine is a prevalent and debilitating neurological disorder. It is characterised by unilateral, throbbing, or pulsating pain that can range …

NHS boss praises managers and leaders as Tories seek to scrap £1bn funding

The chief executive of the National Health Service (NHS) England spoke about her desire to ‘bolster management and leadership’ after …